Category: Pfizer Inc

FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant

An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.
FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.
Reassessing Engine No. 1’s Fight Against Exxon Mobil

As investors press Exxon Mobil on climate issues, activists say that a hedge fund’s eco-focused victory over the oil giant two years ago has achieved little.
FDA Panel

A committee of experts voted in favor of a new shot administered to pregnant women, one in a series of new ways to arm the very young against a life-threatening virus.
Senators and Sam Altman, OpenAI’s CEO, Debate How to Regulate AI

Lawmakers and Sam Altman, the chief executive of OpenAI, agreed that artificial intelligence should be regulated. How to do that remains an open question.
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

The New York Times – Business:
While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
F.D.A. Approves New Nasal Spray for Migraines

The New York Times – Business:
Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.
Leave Russia? A Year Later Many Companies Can’t, or Won’t.

The New York Times – Business:
Not all Western companies packed up and left Russia after its invasion of Ukraine. Some say Moscow has tied their hands, while others choose to stay put.
No Increased Stroke Risk Linked to Pfizer’s Covid Boosters, Federal Officials Say

The New York Times – Business:
An uptick hinted at in surveillance data was a mirage, the officials said.
China’s Abrupt Covid Pivot Leaves Many Without Medicines

The New York Times – Business:
Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.

The New York Times – Business:
The shots may help older, pregnant and immunocompromised Americans dodge serious illness or death. But the doses are not likely to prevent infections in any group, recent studies suggest.
Scientists Are Gaining On RSV, a Persistent Threat to Children

The New York Times – Business:
Vaccines and treatments are in trials, but the virus remains a leading killer of infants worldwide.